Controversies in Stroke Management

Please Note: This CME activity has expired. You may continue to view the material for educational purposes, but this activity is no longer eligible for CME credit.

Course Objectives:
This CME-certified monograph is intended for: Physicians who manage patients following an acute stroke (including neurologists, neurosurgeons, neuro-intensivists, neurointerventional radiologists, and vascular surgeons). Physicians who manage blood pressure in critically ill neurologic patients (including intensivists and any other physician who manages patients in the critical care setting). Emergency physicians who initially manage patients following an acute stroke.

Upon completing this activity, you should be able to:

• Better understand the benefits of surgical intervention in patients with intracerebral hemorrhage.
• Utilize current blood pressure management strategies with parenteral anti-hypertensive treatment options to optimally manage the patient with stroke.
• Understand the role of both intravenous and intra-arterial thrombolysis and utilize as clinically indicated in the management of the patient with ischemic stroke.
• Understand and utilize current patient assessment tools such as PET in the diagnosis and management of the patient with stroke.
• Understand the need for accurate diagnosis and subsequent treatment benefits afforded by early identification of the penumbra in the patient with ischemic stroke.

Accreditation:
Millennium CME Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

Millennium CME Institute, Inc. designates this educational activity for a maximum of .75 Category 1 Credit toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

This activity was prepared in accordance with the ACCME Essentials.

This activity was reviewed for relevance, accuracy of content, balance of presentation, and time required for participation by Adnan I. Qureshi, MD; Ammar Alkawi, MD; Nazli Janjua, MD; and Jawad Kirmani, MD.

Release Date: April 2005

Expiration Date: April 30, 2006

© 2005 Millennium CME Institute, Inc. and UMDNJ—Center for Continuing and Outreach Education

Faculty Disclosure:
Millennium CME Institute, Inc. endorses the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support. Every effort has been made to encourage faculty to disclose any commercial relationships or personal benefit with companies whose products are discussed in educational presentations. Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

The faculty listed below have declared that they have no financial arrangements or affiliations with any corporate organization offering financial support or grant monies for this CME program or with any corporate organization whose product(s) will be discussed in their presentation(s):

• David C. Howard
• Tim Robinson
• John Warren
• Ammar Alkawi, MD
• Nazli Janjua, MD
• Jawad Kirmani, MD

The faculty listed below have declared the following arrangements and/or affiliations:

James C. Grotta, MD: Grant/Research Support—AstraZeneca, Novo Nordisk; Consultant—ESP Pharma
Adnan I. Qureshi, MD: Grant/Research Support—Boston Scientific; Centocor Therapeutics; Cor Therapeutics; Cordis Corporation; C.R. Bard, Inc.; ESP Pharma; Pfizer; San Francisco Science/PICS; Consultant—Boston Scientific

Signed Disclosure forms are on file at Millennium CME Institute, Inc.Signed Disclosure forms are on file at Millennium CME Institute, Inc.

The opinions expressed in this publication are those of the participating faculty and do not necessarily reflect the opinions or the recommendations of their affiliated institutions; University of Medicine & Dentistry of New Jersey; Millennium CME Institute, Inc.; or any other persons. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this publication should not be used by clinicians without evaluation of their patients conditions, assessment of possible contraindications or dangers in use, review of any applicable manufacturers product information, and comparison with the recommendation of other authorities. This Stroke Management Express Report^TM was made possible through an unrestricted educational grant from ESP Pharma.

This CME-certified monograph contains information on commercial products that is outside of current FDA-approved labeling or information on the investigational use of products not yet approved by the FDA.

Directions:
The learner should read the learning objectives and study the publication. After analyzing the material, the learner should complete the Activity Self-assessment Test consisting of a series of multiple-choice questions.

Upon completing this activity as designed, described above, participants will receive a letter of credit awarding AMA/PRA Category 1 Credit six (6) weeks after receipt of the test, registration, and evaluation materials.

Estimated time to complete this activity as designed is .75 hour.

CME Testing Options